Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-037889
Filing Date
2025-03-12
Accepted
2025-03-12 16:00:05
Documents
1
Period of Report
2025-03-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4069
  Complete submission text file 0000950170-25-037889.txt   5551
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Sarraf Pasha (Reporting) CIK: 0002059447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38327 | Film No.: 25731618